RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

E-mail. It was fairly lengthy but vague as you can imagine. All I got was that BP has been more interested in later stage programs and the best case scenario for Cor was to remain independent, continue independent, get back on their feet through financing and licensing, and go forward proving robust proof of concept.

Not a good measure for current shareholders but probably a decent opportunity for future shareholders once the terms of a deal surface. I won't sell here but I surely wouldn't be a buyer either. I may average down at a later stage. More wait and see in my opinion, but I was appreciative of his correspondence.